Zeon (TSE:4205) Could Be 28% Below Fair Value Following Strong First Quarter Earnings

Why Zeon Stock Is Back In Focus After First Quarter Earnings

Zeon (TSE:4205) is drawing fresh attention after reporting first quarter figures to June 30, 2026, with sales of ¥109,466 million and net income of ¥12,711 million, both above last year’s levels.

See our latest analysis for Zeon.

Even with the strong first quarter update, Zeon’s short term share price performance has cooled slightly. The 30 day share price return is down 2.73%, while the 90 day share price return of 19.20% and 1 year total shareholder return of 43.71% point to earlier momentum that is still reflected in longer term results.

If Zeon’s recent move has you thinking about where else growth stories could be forming, this is a good moment to scan 10 top founder-led companies

Bulls point to Zeon’s stronger first quarter figures and recent share price gains. Bears see the softer near term returns and question how much upside is left. The valuation numbers help show which view current evidence supports.

Price-to-Earnings of 10.4x for Zeon: Is It Justified?

On the numbers, Zeon looks inexpensive compared to its peers. The stock closed at ¥2,244 while trading on a P/E of 10.4x that sits well below both its peer group average of 53.6x and the broader JP Chemicals industry average of 12.6x.

The P/E ratio tells you what investors are currently paying for each unit of earnings. For a business like Zeon, which operates across elastomer and high performance materials, the P/E is a useful shorthand for how the market is weighing its earnings profile against other chemical companies.

Current evidence points to the market pricing Zeon at a discount despite a mix of data points. Earnings grew 62.4% over the past year and its net profit margin is 9.9% compared with 6.1% a year earlier. However, analysts expect earnings to decline by an average of 3.1% per year over the next 3 years and forecast Return on Equity at 8.4% in 3 years, which is described as low. The SWS fair P/E ratio estimate of 12.8x is higher than the present 10.4x, which indicates a level the market could move towards if sentiment and earnings expectations align more closely with that fair value marker.

At the industry level, the comparison is clear. Zeon trades on a 10.4x P/E, below the JP Chemicals industry average of 12.6x and far below the 53.6x peer group average quoted in the data, which implies the stock is priced more conservatively than many rivals on current earnings.

Explore the SWS fair ratio for Zeon

Result: Price-to-Earnings of 10.4x (UNDERVALUED)

However, the recent 30 day share price decline and analyst expectations for earnings to fall over the next few years could challenge the current Zeon valuation story.

Find out about the key risks to this Zeon narrative.

Another View On Zeon Using Cash Flows

The P/E gap makes Zeon look inexpensive, and the SWS DCF model points the same way. At ¥2,244 the stock trades below an estimated future cash flow value of ¥3,129.91. Both earnings and cash flow views indicate possible undervaluation. The question is how much weight you give to each signal.

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Zeon for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 19 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With Zeon showing both appealing valuation signals and some areas of concern, this is a good time to review the full picture and move quickly to form your own view using the 3 key rewards and 3 important warning signs

Looking For More Ideas Beyond Zeon?

If Zeon has sharpened your focus on valuation and quality, do not stop here. The next set of opportunities could sit in plain sight if you know where to look.

• Spot potential bargains early by scanning companies that screen well on quality and valuation using the 19 high quality undervalued stocks.
• Prioritise staying power by reviewing stocks with robust finances through the solid balance sheet and fundamentals stocks screener (38 results).
• Hunt for potential future favourites before the crowd by checking the screener containing 63 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com